Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. South Africa
  4. Johannesburg Stock Exchange
  5. Aspen Pharmacare Holdings Limited
  6. Summary
    APN   ZAE000066692

ASPEN PHARMACARE HOLDINGS LIMITED

(APN)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Johannesburg Stock Exchan…
09/17/2021 09/20/2021 09/21/2021 09/22/2021 09/23/2021 Date
236.22 238.67 240.42 240.38 250 Last
3826088 1919751 1589757 706412 2384397 Volume
+2.59% +1.04% +0.73% -0.02% +4.00% Change
Estimated financial data (e)
Sales 2021 37 639 M 2 518 M 2 518 M
Net income 2021 5 106 M 342 M 342 M
Net Debt 2021 20 146 M 1 348 M 1 348 M
P/E ratio 2021 22,5x
Yield 2021 0,94%
Sales 2022 42 882 M 2 869 M 2 869 M
Net income 2022 6 951 M 465 M 465 M
Net Debt 2022 8 444 M 565 M 565 M
P/E ratio 2022 16,4x
Yield 2022 1,23%
Capitalization 114 B 7 599 M 7 619 M
EV / Sales 2021 3,56x
EV / Sales 2022 2,85x
Nbr of Employees 9 469
Free-Float 84,2%
More Financials
Company
Aspen Pharmacare Holdings Limited is a South Africa-based global specialty and branded pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both active pharmaceutical ingredients (APIs) and finished dose form. The Company is focused on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both... 
Sector
Pharmaceuticals
Calendar
12/09
More about the company
Ratings of Aspen Pharmacare Holdings Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about ASPEN PHARMACARE HOLDINGS LIMITED
09/21ASPEN PHARMACARE HOLDINGS LIMITED : Ex-dividend day for final dividend
FA
09/10Suitors Offer to Buy Aspen's Parts of Business
CI
09/03Aspen Pharmacare Holdings Limited Announces Board Changes, Effective from 9 December 20..
CI
09/03EUROPEAN MIDDAY BRIEFING : Stocks Trade Mixed Ahead of U.S. Jobs Report
DJ
09/03RICHARD BRANSON : Stocks to Waver Ahead of -2-
DJ
09/02S.Africa's Aspen seeks licence for J&J COVID shot as EU shipments halted
RE
09/02Aspen eyes Serum Institute model as it seeks licence to make J&J vaccine
RE
09/02ASPEN PHARMACARE : Alert and story withdrawn on Aspen and J&J in talks to produce COVID va..
RE
09/02ASPEN PHARMACARE : S.Africa's Aspen and J&J in talks to produce COVID vaccine
RE
09/01ASPEN PHARMACARE : increases revenue from continuing operations by 12% to R37,8 billion
PU
09/01ASPEN PHARMACARE : Earnings Document
PU
08/27ASPEN PHARMACARE : BioNTech eyes Rwanda, Senegal for malaria, tuberculosis vaccine product..
RE
08/27ASTRAZENECA : BioNTech eyes Rwanda, Senegal for malaria, tuberculosis vaccine production
RE
08/05SEAN CAPAZORIO : S.Africa's Aspen names company veteran Capazorio as finance chief
RE
08/05Aspen Pharmacare Holdings Limited Announces Changes to the Board
CI
More news
News in other languages on ASPEN PHARMACARE HOLDINGS LIMITED
09/02CORONA-BLOG/WHO : Großteil afrikanischer Staaten verfehlt Impfziel
09/02Aspen (Afrique du Sud) demande une licence pour le vaccin COVID de J&J alors que les ex..
09/02CORONA-BLOG/EU gibt Millionen aus Afrika importierte Impfstoffdosen zurück
09/02ASPEN PHARMACARE : Los envíos de vacunas de J&J de Sudáfrica a Europa, interrumpidos
09/02Aspen (Afrique du Sud) et J&J en pourparlers pour produire le vaccin COVID
More news
Chart ASPEN PHARMACARE HOLDINGS LIMITED
Duration : Period :
Aspen Pharmacare Holdings Limited Technical Analysis Chart | APN | ZAE000066692 | MarketScreener
Technical analysis trends ASPEN PHARMACARE HOLDINGS LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 250,00 ZAR
Average target price 238,80 ZAR
Spread / Average Target -4,48%
EPS Revisions
Managers and Directors
Stephen Bradley Saad Group Chief Executive Officer & Executive Director
Michael Guy Attridge Finance Director & Executive Director
Sean Matthew Capazorio Group Finance Officer
Kuseni Douglas Dlamini Chairman
Lorraine Angela Hill Group Operating Officer